Newsfeeds - Spark Newswire

2 minute read

News

Annovis Bio’s CEO Maria Maccecchini Issues Letter To Stockholders

Today, 4:24 AM

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases, today released the following letter to stockholders from

ANVS

1 minute read

HC Wainwright & Co. Initiates Coverage On Annovis Bio with Buy Rating, Announces Price Target of $40

By Benzinga Newsdesk

Today, 4:24 AM

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Annovis Bio (NYSE:ANVS) with a Buy rating and announces Price Target of $40.

ANVS

2 minute read

Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

Today, 4:24 AM

The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene…

AIMD

6 minute read

83 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:24 AM

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.

ACLX

1 minute read

Ladenburg Thalmann Initiates Coverage On Annovis Bio with Buy Rating, Announces Price Target of $37

By Benzinga Newsdesk

Today, 4:24 AM

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Annovis Bio (NYSE:ANVS) with a Buy rating and announces Price Target of $37.

ANVS

48 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 4:24 AM

During Thursday, 849 stocks hit new 52-week lows.

AADI

33 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 4:24 AM

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.